Cutaneous involvement in luteinized thecomas with sclerosing peritonitis (<scp>LTSP</scp>)—A new finding in a rare syndrome

Ho, Jonathan; Bhawan, Jag; O’Brien, Michael J.; Goldberg, Lynne J.

doi:10.1111/cup.12990

Cited by 2 publications

(1 citation statement)

References 7 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some patients have had a prior history of anticonvulsant or propranolol therapy or autoimmune disease, 64,150,151 and a few elevated CA-125 serum levels 153 . Rarely extraperitoneal involvement has been described including cutaneous 165 and extraperitoneal lesions 148 . Patients suffer from complications related to their peritoneal disease, most often bowel obstruction that in the past resulted in high morbidity and up to 30% mortality; symptoms may develop after the resection of ovarian lesions and may persist for months 143,149 .…”

Section: Luteinized Thecoma With Sclerosing Peritonitismentioning

confidence: 99%

Sex Cord–Stromal Tumors of the Ovary: An Update and Review. Part I — Pure Ovarian Stromal Tumors

Devins,

Young,

Oliva

2024

Advances in Anatomic Pathology

View full text Add to dashboard Cite

In two separate reviews, we reviews the time-honored but still frequently challenging features of ovarian sex cord–stromal tumors, and also emphasize new developments including unusual morphologic appearances that, despite the relative rarity of many of the tumors, result in a disproportionate number of differential diagnostic problems, variant immunohistochemical profiles, and specific molecular and syndromic associations. These neoplasms are also of historical interest as current knowledge is still based in significant part on the contributions of 2 giants of gynecologic pathology, Dr Robert Meyer and Dr Robert E. Scully. In part I, we present the major clinical, pathologic, and genomic features of the pure ovarian stromal tumors including comments on differential diagnosis and briefly note significant historical contributions. In part II we will discuss pure sex cord and sex cord–stromal tumors.

show abstract